Blueprint Medicines (Netherlands) B.V.
SpainAll drugs from this manufacturer
-
It is used to treat adults with a type of digestive system cancer called gastrointestinal stromal tumor (GIST) that has a specific mutation, or to treat disorders known as advanced systemic mastocytosis (ASM).
Dosage form: tablets, film-coated
Active substance Dosage avapritinib 100 mg -
It is used to treat adults with a type of digestive system cancer called gastrointestinal stromal tumor (GIST) that has a specific mutation and cannot be treated with surgery or has spread. It is also used to treat advanced systemic mastocytosis (ASM), which includes aggressive systemic mastocytosis, systemic mastocytosis with associated hematological neoplasm, or mast cell leukemia.
Dosage form: tablets, film-coated
Active substance Dosage avapritinib 200 mg -
It is used to treat adults with advanced systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL) who have already received at least one prior treatment.
Dosage form: tablets, film-coated
Active substance Dosage avapritinib 25 mg -
It is used in adults to treat a type of digestive system cancer called gastrointestinal stromal tumor (GIST) that cannot be treated with surgery or that has spread to other parts of the body, provided it presents a specific mutation (D842V).
Dosage form: tablets, film-coated
Active substance Dosage avapritinib 300 mg -
It is used to treat adults with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast细胞 leukemia (ML) who have already received at least one previous treatment.
Dosage form: tablets, film-coated
Active substance Dosage avapritinib 50 mg